Clinical Deep Data Accumulation System (CLIDAS) reveals lipid paradox in guideline-defined high risk Japanese patients after PCI
Tetsuya Matoba(Kyushu University), R Nagai(The University of Tokyo), A Kiyosue(University of Tokyo Hospital), Hiroki Sato(National Defense Medical College), Kenichi Tsujita(Kumamoto University), Taishi Nakamura(Kumamoto University), Kotaro Nochioka(Tohoku University), T Kabutoya(Jichi Medical University), Yoshitaka Iwanaga(National Cerebral and Cardiovascular Center), Takahide Kohro(Jichi Medical University), Yoshihiro Miyamoto(Asahikawa City Hospital), Yoshiko Mizuno(Development Bank of Japan), Hiroyuki Tsutsui(Juntendo University), Masaaki Nakayama(Okayama University), Hideo Fujita(The University of Tokyo)
Cited by 1
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
|Nature Medicine|2002|4.2k
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821
Mitochondrial Electron Transport Complex I Is a Potential Source of Oxygen Free Radicals in the Failing Myocardium
|Circulation Research|1999|700
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582